Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1155/2017/2714095 http://scihub22266oqcxt.onion/10.1155/2017/2714095 C5439179!5439179!28566800     free     free     free Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Dis+Markers 2017 ; 2017 (ä): ä Nephropedia Template TP {{tp|p=28566800|t=2017. Serum Soluble ST2 and Diastolic Dysfunction in Hypertensive Patients |pdf=|usr=}}{{28566800}} gab.com Text Serum Soluble ST2 and Diastolic Dysfunction in Hypertensive Patients JO: Dis Markers http://www.kidney.de/pget.php?&tw=1&pmid=28566800 #FOAvip Background: Echocardiographic evaluation of left ventricular (LV) structural and functional alterations in hypertension has some limitations, potentially overcome by using biomarkers. ST2, a prognostic biomarker for heart failure and myocardial infarction patients, was less studied in hypertension. Aim: To analyze the relationship between serum ST2 levels and diastolic dysfunction (DD) in hypertension. Method: We enrolled 88 hypertensive outpatients (average age 65 years, 69.3% females) in a prospective study, stratified for presence of LV hypertrophy (LVH). For each patient clinical examination, lab workup (routine and serum ST2 levels) and echocardiography were performed. Results: Hypertensive patients with LVH had higher age, pulse pressure, mean arterial pressure, and serum ST2, while having lower serum albumin than those without LVH. Serum ST2 levels correlate with parameters of LV remodeling and DD. We found that 5.3% of ST2 level variability was caused by a 1-unit variation of cardiovascular risk. We identified cut-off values for discriminating hypertension with LVH versus that without LVH and grade 2 DD versus normal diastolic performance. Conclusion: ST2 could be used as diagnostic biomarker for cardiac remodeling and altered diastolic performance in hypertension, providing additional data to echocardiography. It could represent a milestone in early detection of cardiac performance alteration. Twit Text FOAVip Serum Soluble ST2 and Diastolic Dysfunction in Hypertensive Patients ????Dis Markers http://www.kidney.de/pget.php?&tw=1&pmid=28566800 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=28566800 #FOAvip English Wikipedia <ref>{{Cite pmid|28566800}}</ref> Serum Soluble ST2 and Diastolic Dysfunction in Hypertensive Patients #MMPMID28566800 Farca? AD; Anton FP; Goidescu CM; Gavril? IL; Vida-Simiti LA; Stoia MA Dis Markers 2017[]; 2017 (ä): ä PMID28566800show ga Background: Echocardiographic evaluation of left ventricular (LV) structural and functional alterations in hypertension has some limitations, potentially overcome by using biomarkers. ST2, a prognostic biomarker for heart failure and myocardial infarction patients, was less studied in hypertension. Aim: To analyze the relationship between serum ST2 levels and diastolic dysfunction (DD) in hypertension. Method: We enrolled 88 hypertensive outpatients (average age 65 years, 69.3% females) in a prospective study, stratified for presence of LV hypertrophy (LVH). For each patient clinical examination, lab workup (routine and serum ST2 levels) and echocardiography were performed. Results: Hypertensive patients with LVH had higher age, pulse pressure, mean arterial pressure, and serum ST2, while having lower serum albumin than those without LVH. Serum ST2 levels correlate with parameters of LV remodeling and DD. We found that 5.3% of ST2 level variability was caused by a 1-unit variation of cardiovascular risk. We identified cut-off values for discriminating hypertension with LVH versus that without LVH and grade 2 DD versus normal diastolic performance. Conclusion: ST2 could be used as diagnostic biomarker for cardiac remodeling and altered diastolic performance in hypertension, providing additional data to echocardiography. It could represent a milestone in early detection of cardiac performance alteration. äSerum Soluble ST2 and Diastolic Dysfunction in Hypertensive Patients (epmc).pdf DeepDyve Pubget Overpricing